Chargement en cours...
Interleukin 17 Selectively Predicts Better Outcomes with Bupropion-SSRI Combination: Novel T Cell Biomarker for Antidepressant Medication Selection
BACKGROUND: Interleukin 17 (IL-17) is produced by highly inflammatory Th17 cells and has been implicated in pathophysiology of depression. IL-17 putatively disrupts the blood brain barrier and affects dopamine synthesis whereas dopamine has been shown to decrease Th17 cell-mediated immune response....
Enregistré dans:
| Publié dans: | Brain Behav Immun |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5699207/ https://ncbi.nlm.nih.gov/pubmed/28698115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbi.2017.07.005 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|